Skip to main content
TryTrutide

Conflicts of Interest Policy

TryTrutide requires relevant financial and professional relationships to be disclosed by authors and reviewers.

Last updated: September 2026

Disclosure Requirements

All authors and medical reviewers are required to disclose relevant financial relationships, employment, consulting arrangements, equity interests, or other relationships that could reasonably be perceived as influencing their work. Disclosures are displayed on articles where applicable.

Editorial Staff

TryTrutide editorial staff disclose relevant relationships at the organizational level. TryTrutide is not affiliated with, employed by, or financially dependent on Eli Lilly, any compounding pharmacy, any clinical trial sponsor, or any entity with a direct financial interest in retatrutide's regulatory outcome.

Founder Disclosure

AJ Pakpour is the founder and publisher of TryTrutide. He does not hold equity in Eli Lilly or any retatrutide-related commercial entity. He is not a licensed physician and does not provide clinical recommendations.

Reporting Undisclosed Conflicts

If you believe a conflict of interest has not been disclosed, please contact the editorial team with details.

← Editorial Policy
Related Reading